Skip to main content

Psychopharmacology of substance misuse and comorbid psychiatric disorders

Buy Article:

$43.00 plus tax (Refund Policy)

Abou-Saleh MT. Psychopharmacology of substance misuse and comorbid psychiatric disorders.

The common occurrence of comorbid substance misuse and other psychiatric disorders has challenged the diagnostic and therapeutic skills of professionals concerned with the care of patients with these dual disorders. Combined pharmacological and psychological treatment approaches have evolved empirically drawing upon standard treatments with emphasis on psychosocial approaches to substance misuse for psychotic disorders and pharmacological approaches for mood disorders. Advances in the biology of both disorders have started to inform their psychopharmacology. The specific role of atypical antipscychotics is highlighted. Further studies of the biology of comorbidity will impact the use of effective pharmaceuticals such as clozapine with dual effects on schizophrenia and substance misuse.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: comorbid; psychiatric; psychopharmacology substance misuse

Document Type: Research Article

Affiliations: South-West London and St George's NHS Trust, London, UK

Publication date: 2004-02-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more